1. Home
  2. DLPN vs ALLR Comparison

DLPN vs ALLR Comparison

Compare DLPN & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.60

Market Cap

20.6M

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.25

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
ALLR
Founded
1996
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
19.3M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DLPN
ALLR
Price
$1.60
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.50
AVG Volume (30 Days)
31.2K
180.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.81
N/A
EPS
N/A
N/A
Revenue
$51,684,984.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.75
$0.61
52 Week High
$1.88
$2.35

Technical Indicators

Market Signals
Indicator
DLPN
ALLR
Relative Strength Index (RSI) 54.16 61.86
Support Level $1.51 $0.99
Resistance Level $1.71 $1.34
Average True Range (ATR) 0.06 0.11
MACD -0.00 0.03
Stochastic Oscillator 57.89 67.73

Price Performance

Historical Comparison
DLPN
ALLR

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: